Copyright © 1993 by the European Society of Cardiology.
© 1993 The Europen Society of Cardiology
Return to work following coronary artery bypass surgery or percutaneous transluminal coronary angioplasty
Department of Cardiology, Beaumont Hospital Dublin 9, Ireland
Received 5 October 1992; revised 24 November 1992; .
Correspondence: Dr Hannah McGee, Department of Cardiology, Beaumont Hospital, P.O. Box 1297, Dublin 9, Ireland
Abstract
Return to work (RTW) and other treatment outcomes of coronary artery bypass graft (CABG) and percutaneous transluminal coronary angioplasty (PTCA) patients were compared. Consecutive patients at one centre (n = 112 CABG and 119 PTCA patients) were interviewed 618 months following treatment (groups were similar in sex and social class). Pre-treatment employment levels were similar (41 and 38% for CABG and PTCA groups, respectively). PTCA patients were more likely to smoke, have angina, have less advanced cardiovascular disease and have been advised to stop working for medical reasons pre-treatment. Post-treatment levels of employment increased significantly. RTW rates were similar for CABG and PTCA groups (59 and 68% respectively). Both groups had reduced smoking to similar levels. The PTCA group continued to have higher levels of angina. For those without angina, PTCA patients were significantly more likely to return to work (73 vs 55%, P<0.01). Both CABG and PTCA resulted in increased employment post-treatment.
Key Words: Coronary bypass surgery coronary angioplasty return to work
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Perk and K. Alexanderson Chapter 8. Sick leave due to coronary artery disease or stroke Scand J Public Health, October 1, 2004; 32(63_suppl): 181 - 206. [Abstract] [PDF] |
||||
![]() |
S. J. Pocock, R. A. Henderson, P. Seed, T. Treasure, and J. R. Hampton Quality of Life, Employment Status, and Anginal Symptoms After Coronary Angioplasty or Bypass Surgery: 3-Year Follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial Circulation, July 15, 1996; 94(2): 135 - 142. [Abstract] [Full Text] |
||||

